naringenin has been researched along with 20-hydroxy-5,8,11,14-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J; Zou, X | 1 |
1 other study(ies) available for naringenin and 20-hydroxy-5,8,11,14-eicosatetraenoic acid
| Article | Year |
|---|---|
Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
Topics: Animals; Cell Line; Cell Proliferation; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Female; Flavanones; Glucose; Hydroxyeicosatetraenoic Acids; Kidney; Mice; Peroxisome Proliferator-Activated Receptors; Rats; Streptozocin; Up-Regulation | 2019 |